Capaldi D, Ackley K, Brooks D, Carmody J, Draper K, Kambhampati R, Kretschmer M, Levin D, McArdle J, Noll B, Raghavachari R, Roymoulik I, Sharma BP, Thürmer R, Wincott F

Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients. Drug Information Journal 46 (5), 2012, 611-626.

Cremer-Schaeffer P, Radbruch L

Palliative care in the light of legal and regulatory requirements in Germany. Bundesgesundheitsblatt 55 (2), 2012, 231-237.

Eckstein N, Haas B

Platinum-based chemotherapy in triple negative breast cancer. Deutsche Medizinische Wochenschrift 137, 2012, 333-336.

Fischer T, Renisch B, Broich K

Authorization procedure of clinical trials with medical devices. First practical analysis of the BfArM. Bundesgesundheitsblatt 55 (2), 2012, 270-276.

Mayer P

Chances and risks of SGLT2 inhibitors. Archives of Pharmacology 2012 (Dez 24), doi: 10.1007/s00210-011-0720-0.

Mayer P, Reitzenstein U, Warnken M, Enzmann H, Racké K

Insulin action on H292 bronchial carcinoma cells as compared to normal bronchial epithelial cells. Pulmonary Pharmacology and Therapeutics 25, 2012, 104-114.

Schmidt T, Zündorf J, Grüger T, Brandenburg K, Reiners AL, Zinserling J, Schnitzler N

CD66b overexpression and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive stimulus. Journal of Leukocyte Biology 2012, published online 8. Februar 2012, DOI: 10.1189/jlb.0911483.

Schmidt T, Zündorf J, Grüger T, Brandenburg K, Reiners AL, Zinserling J, Witte W, Schnitzler N

Phenotyping of Staphylococcus aureus reveals a new virulent ST398 lineage. Clinical Microbiology and Infection 2012, published online, DOI: 10.1111/j.1469-0691.2012.03775.x.